Wells Fargo & Company Supernus Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 55,245 shares of SUPN stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,245
Previous 48,801 13.2%
Holding current value
$1.87 Million
Previous $1.66 Million 11.24%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$25.99 - $33.85 $167,479 - $218,129
6,444 Added 13.2%
55,245 $1.48 Million
Q1 2024

May 10, 2024
BUY
$27.11 - $35.17 $63,084 - $81,840
2,327 Added 5.01%
48,801 $1.66 Million
Q4 2023

Feb 09, 2024
SELL
$22.72 - $29.68 $12,473 - $16,294
-549 Reduced 1.17%
46,474 $1.34 Million
Q3 2023

Nov 13, 2023
SELL
$27.57 - $32.91 $407,236 - $486,113
-14,771 Reduced 23.9%
47,023 $1.3 Million
Q2 2023

Aug 15, 2023
BUY
$29.91 - $38.73 $301,223 - $390,049
10,071 Added 19.47%
61,794 $1.86 Million
Q1 2023

May 12, 2023
BUY
$34.93 - $42.03 $352,443 - $424,082
10,090 Added 24.24%
51,723 $1.87 Million
Q4 2022

Feb 13, 2023
SELL
$31.09 - $37.88 $243,279 - $296,411
-7,825 Reduced 15.82%
41,633 $1.49 Million
Q3 2022

Nov 14, 2022
SELL
$28.79 - $35.41 $109,574 - $134,770
-3,806 Reduced 7.15%
49,458 $1.67 Million
Q2 2022

Aug 12, 2022
SELL
$25.33 - $34.25 $1.35 Million - $1.82 Million
-53,174 Reduced 49.96%
53,264 $1.54 Million
Q1 2022

May 16, 2022
SELL
$28.51 - $32.9 $351,471 - $405,591
-12,328 Reduced 10.38%
106,438 $3.44 Million
Q4 2021

Feb 14, 2022
SELL
$26.37 - $34.22 $623,413 - $808,995
-23,641 Reduced 16.6%
118,766 $3.46 Million
Q3 2021

Nov 15, 2021
BUY
$23.54 - $31.39 $407,147 - $542,921
17,296 Added 13.82%
142,407 $3.8 Million
Q2 2021

Aug 16, 2021
SELL
$26.72 - $33.19 $2.33 Million - $2.89 Million
-87,065 Reduced 41.03%
125,111 $3.85 Million
Q1 2021

May 13, 2021
BUY
$24.15 - $31.45 $1.9 Million - $2.48 Million
78,857 Added 59.15%
212,176 $5.56 Million
Q4 2020

Feb 09, 2021
SELL
$17.7 - $25.81 $128,289 - $187,070
-7,248 Reduced 5.16%
133,319 $3.35 Million
Q3 2020

Nov 05, 2020
BUY
$20.2 - $25.05 $240,703 - $298,495
11,916 Added 9.26%
140,567 $2.93 Million
Q2 2020

Aug 13, 2020
BUY
$17.09 - $24.89 $164,439 - $239,491
9,622 Added 8.08%
128,651 $3.06 Million
Q1 2020

May 14, 2020
BUY
$14.45 - $24.69 $1.72 Million - $2.94 Million
119,029 New
119,029 $2.14 Million

Others Institutions Holding SUPN

# of Institutions
255
Shares Held
59.2M
Call Options Held
47.9K
Put Options Held
13.1K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.81B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email